Search

Your search keyword '"Firinu, D"' showing total 215 results

Search Constraints

Start Over You searched for: Author "Firinu, D" Remove constraint Author: "Firinu, D"
215 results on '"Firinu, D"'

Search Results

1. Impact of Menopause in Patients with Multiple Sclerosis: Current Perspectives

3. Rare connective tissue diseases in patients with C1-inhibitor deficiency hereditary angioedema: first evidence on prevalence and distribution from a large Italian cohort study.

4. Immunoglobulin free light chains in severe asthma patient: Could they be a new biomarker?

5. Immunoglobulin free light chains in severe asthma patient: Could they be a new biomarker?

6. Antihypertensive treatment changes and related clinical outcomes in older hospitalized patients

7. Clinical features and outcomes of elderly hospitalised patients with chronic obstructive pulmonary disease, heart failure or both

8. Correction to: Prescription appropriateness of anti-diabetes drugs in elderly patients hospitalized in a clinical setting: evidence from the REPOSI Register (Internal and Emergency Medicine, (2023), 18, 4, (1049-1063), 10.1007/s11739-023-03254-3)

9. Prescription appropriateness of anti-diabetes drugs in elderly patients hospitalized in a clinical setting: evidence from the REPOSI Register

10. COVID-19 vaccination in patients receiving allergen immunotherapy (AIT) or biologicals—EAACI recommendations

11. Mepolizumab for Eosinophilic Granulomatosis With Polyangiitis: A European Multicenter Observational Study

12. The multifaceted spectrum of liver cirrhosis in older hospitalised patients: Analysis of the REPOSI registry

13. Pattern of comorbidities and 1-year mortality in elderly patients with COPD hospitalized in internal medicine wards: data from the RePoSI Registry

14. Hyperglycemia at admission, comorbidities, and in-hospital mortality in elderly patients hospitalized in internal medicine wards: data from the RePoSI Registry

15. Underdiagnosis and undertreatment of osteoporotic patients admitted in internal medicine wards in Italy between 2010 and 2016 (the REPOSI Register)

16. Comparing the responses of countries and National Health Systems to the COVID-19 pandemic: a critical analysis with a case-report series.

17. Underdiagnosis and undertreatment of osteoporotic patients admitted in internal medicine wards in Italy between 2010 and 2016 (the REPOSI Register)

18. The multifaceted spectrum of liver cirrhosis in older hospitalised patients: Analysis of the REPOSI registry

19. Mepolizumab for Eosinophilic Granulomatosis with Polyangiitis (EGPA): a European multicenter observational study

20. Is the Inversion in the Trend of the Lethality of the COVID-19 in the Two Hemispheres due to the Difference in Seasons and Weather?

21. Anwendung von Biologika bei allergischen und Typ-2- entzündlichen Erkrankungen in der aktuellen COVID-19-Pandemie – ein Positionspapier von AeDA, DGAKI, GPA, ÖGAI, LGAI, ÖGP, ARIA und EAACI

22. COVID-19 vaccination in patients receiving allergen immunotherapy (AIT) or biologicals—EAACI recommendations

23. Antibiotic use and associated factors in a large sample of hospitalised older people

24. Patterns of infections in older patients acutely admitted to medical wards: data from the REPOSI register

25. Prevalence of use and appropriateness of antidepressants prescription in acutely hospitalized elderly patients

26. Mortality rate and risk factors for gastrointestinal bleeding in elderly patients

27. Hospital Care of Older Patients With COPD: Adherence to International Guidelines for Use of Inhaled Bronchodilators and Corticosteroids

28. Patterns of infections in older patients acutely admitted to medical wards: data from the REPOSI register

30. EAACI Biologicals Guidelines—Recommendations for severe asthma

31. Living alone as an independent predictor of prolonged length of hospital stay and non-home discharge in older patients

32. Polypharmacy in older people: Lessons from 10 years of experience with the REPOSI register

33. Efficacy and safety of treatment with dupilumab for severe asthma : A systematic review of the EAACI guidelines-Recommendations on the use of biologicals in severe asthma

34. Efficacy and safety of treatment with biologicals (benralizumab, dupilumab and omalizumab) for severe allergic asthma: A systematic review for the EAACI Guidelines - recommendations on the use of biologicals in severe asthma

35. Use of biologicals in allergic and type-2 inflammatory diseases during the current COVID-19 pandemic: Position paper of Ärzteverband Deutscher Allergologen (AeDA)A, Deutsche Gesellschaft für Allergologie und Klinische Immunologie (DGAKI)B<

36. Considerations on biologicals for patients with allergic disease in times of the COVID-19 pandemic: An EAACI statement

37. Use of biologicals in allergic and type 2 inflammatory diseases in the current COVID-19 pandemic [Anwendung von biologika bei allergischen und Typ-2-entzündlichen Erkrankungen in der aktuellen COVID-19-Pandemie]

38. Deciphering the genetics of primary angioedema with normal levels of C1 inhibitor

39. Efficacy and safety of treatment with biologicals (benralizumab, dupilumab, mepolizumab, omalizumab and reslizumab) for severe eosinophilic asthma. A systematic review for the EAACI Guidelines - recommendations on the use of biologicals in severe asthma

40. Efficacy and safety of treatment with dupilumab for severe asthma: A systematic review of the EAACI guidelines—Recommendations on the use of biologicals in severe asthma

41. Use of biologicals in allergic and type 2 inflammatory diseases in the current COVID 19 pandemic

42. Drug–drug interactions involving CYP3A4 and p-glycoprotein in hospitalized elderly patients

43. Sex-Differences in the Pattern of Comorbidities, Functional Independence, and Mortality in Elderly Inpatients: Evidence from the RePoSI Register

44. Inappropriate prescription of benzodiazepines in acutely hospitalized older patients

45. Influenza burden, prevention, and treatment in asthma-A scoping review by the EAACI Influenza in asthma task force

46. Disability, and not diabetes, is a strong predictor of mortality in oldest old patients hospitalized with pneumonia

47. Prevalence, characteristics and treatment of chronic pain in elderly patients hospitalized in internal medicine wards

48. Prognostic relevance of glomerular filtration rate estimation obtained through different equations in hospitalized elderly patients

49. Influenza burden, prevention, and treatment in asthma‐A scoping review by theEAACIInfluenza in asthma task force

50. Therapeutic Duplicates in a Cohort of Hospitalized Elderly Patients: Results from the REPOSI Study

Catalog

Books, media, physical & digital resources